UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549



                                    FORM 8-K



     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934



        Date of Report (Date of earliest event reported): October 4, 2010


                                 IMAGING3, INC.
               ---------------------------------------------------
             (Exact name of registrant as specified in its charter)



                                   CALIFORNIA
               -------------------------------------------------
                 (State or other jurisdiction of incorporation)


     000-50099                                         95-4451059
- ------------------------                  ------------------------------------
(Commission File Number)                  (I.R.S. Employer Identification No.)

                 3200 W. VALHALLA DR., BURBANK, CALIFORNIA 91505
            -------------------------------------------------------
               (Address of principal executive offices) (Zip Code)

       Registrant's telephone number, including area code: (818) 260-0930

                                 NOT APPLICABLE
                      -----------------------------------
              (Former name, former address and former fiscal year,
                         if changed since last report)


Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions.

[_]  Written  communications  pursuant to Rule 425 under the  Securities Act (17
     CFR240.14d-2(b))

[_]  Soliciting  material  pursuant  to  Rule  14a-12  under  Exchange  Act  (17
     CFR240.14a-12)

[_]  Pre-commencement   communications  pursuant  to  Rule  14d-2(b)  under  the
     Exchange Act (17 CFR240.14d-2(b))

[_]  Pre-commencement   communications  pursuant  to  Rule  13e-4(c)  under  the
     Exchange Act (17 CFR240.13e-4(c))



                                TABLE OF CONTENTS


SECTION 1.   REGISTRANT'S BUSINESS AND OPERATIONS..............................1

                 Item 1.01 Entry into a Material Definitive Agreement..........1

SECTION 3.   SECURITIES AND TRADING MARKETS....................................1

                 Item 3.02 Unregistered Sales of Equity Securities.............1

SECTION 9.   FINANCIAL STATEMENTS AND EXHIBITS ................................2

SIGNATURES.....................................................................2






SECTION 1. REGISTRANT'S BUSINESS AND OPERATIONS
- -----------------------------------------------

         Item 1.01 Entry into a Material Definitive Agreement
         ----------------------------------------------------

         Imaging3, Inc., a California corporation (the "Company"),  entered into
a Securities  Purchase Agreement (the "Purchase  Agreement") on October 4, 2010,
with two  institutional  investors for the sale of common stock and warrants for
$1,000,000.22

         The  terms of the  Purchase  Agreement  include  the sale of  4,587,157
shares of common stock at $0.218 per share. The warrants  include:  (i) Series A
Warrants,  which  are  immediately  exercisable  for a  period  of 5 years  into
4,587,157  shares at  $0.2725  per  share;  (ii)  Series B  Warrants,  which are
immediately exercisable for a period of up to 18 months into 4,587,157 shares at
$0.218 per share; and (iii) Series C Warrants, which are immediately exercisable
for a period of 5 years into  4,587,157  shares at $0.2725 per share but only to
the  extent  that  the  Series B  Warrants  are  exercised  and only in the same
percentage  that the  Series B  Warrants  are  exercised.  All of such  warrants
contain  customary  adjustments  for corporate  events such as  reorganizations,
splits,  dividends,  and the exercise prices of all such warrants are subject to
full-ratchet  anti-dilution  adjustments in the event of additional issuances of
common stock below the exercise price then in effect.

         The  closing  of the  transaction  is subject  to the  satisfaction  of
customary  closing  conditions and is expected to occur on or before October 14,
2010.  The net  proceeds  from the  transaction  will be used solely for working
capital purposes.  In the Purchase Agreement,  the Company agreed not to use the
proceeds  to  satisfy  any debt,  to  redeem  any of the  Company's  outstanding
securities or with respect to any litigation involving the Company.

         At the  closing  of the  transaction,  the  Company  will  enter into a
registration  rights agreement (the  "Registration  Rights  Agreement") with the
institutional  investors.  Pursuant to the Registration  Rights  Agreement,  the
Company will be required to file a registration  statement  under the Securities
Act of 1933, as amended (the "Securities Act"), with the Securities and Exchange
Commission  (the "SEC")  covering  the resale of the common stock to be sold and
the  common  stock  underlying  the  warrants  to  be  sold  (the  "Registration
Statement").  The  Company  will be  required  to pay all  expenses  incurred in
connection with the filing of the Registration Statement.  The Company will also
be obligated to use its best efforts to file the  Registration  Statement within
30 days of the closing date of the transaction. In addition, the Company will be
obligated to use its best  efforts to cause the SEC to declare the  Registration
Statement  effective  within 90 days of the closing date of the  transaction (or
120 days in the event that the  Registration  Statement  is subject to review by
the SEC),  and the  Company  will be required  to pay  certain  negotiated  cash
payments  to the  institutional  investors  in the event  that the  Registration
Statement  is not filed  within 30 days of such  closing date or is not declared
effective within 90 days of such closing date (or 120 days in the event that the
Registration Statement is subject to review by the SEC).

SECTION 3. SECURITIES AND TRADING MARKETS
- -----------------------------------------

         Item 3.02.   Unregistered Sales of Equity Securities.
         ----------------------------------------------------

         The  disclosure  provided  in  Item  1.01 of this  Form  8-K is  hereby
incorporated by reference into this Item 3.02.

         Wharton Capital  Partners,  Ltd., a New York based  investment  banking
firm, acted as the placement agent for the Company in the transaction.

                                      -1-


         The  offer,  issuance  and sale by the  Company of the shares of common
stock,  warrants and the shares of common stock  underlying  the warrants in the
transaction  have not been  registered  under the  Securities Act and may not be
offered or sold without  registration  with the SEC under the  Securities Act or
under an applicable exemption from the Securities Act.

         The  description  of the  documents in this current  report on Form 8-K
does not purport to be complete and is qualified in its entirety by reference to
the  Purchase  Agreement,  the form of  Series A  Warrant,  the form of Series B
Warrant,  the form of Series C Warrant and the form of the  Registration  Rights
Agreement,  which  are  filed as  Exhibits  10.1,  10.2,  10.3,  10.4 and  10.5,
respectively, to this report and are incorporated herein by reference.

SECTION 9. FINANCIAL STATEMENTS, PRO FORMA FINANCIALS & EXHIBITS
- ----------------------------------------------------------------

         (a)      Financial Statements of Business Acquired

                  Not Applicable.

         (b)      Pro Forma Financial Information

                  Not Applicable.

         (c)      Shell Company Transactions

                  Not Applicable.

         (d)      Exhibits

                  10.1.    Securities Purchase Agreement dated October 4, 2010

                  10.2     Form of Series A Warrant

                  10.3     Form of Series B Warrant

                  10.4     Form of Series C Warrant

                  10.5     Form of Registration Rights Agreement

                                   SIGNATURES

         Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended,  the  registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.


                                         IMAGING3, INC.
                                         --------------
                                          (Registrant)

Date:  October 5, 2010
                               /s/ Dean Janes, Chief Executive Officer
                               ---------------------------------------
                               Dean Janes, Chief Executive Officer





















                                      -2-